Imatinib Mylan 100 mg Norge - norsk - Statens legemiddelverk

imatinib mylan 100 mg

mylan ab - imatinib - tablett, filmdrasjert - 100 mg

Imatinib Cipla 400 mg Norge - norsk - Statens legemiddelverk

imatinib cipla 400 mg

cipla europe nv - imatinibmesilat - kapsel, hard - 400 mg

Imatinib Cipla 100 mg Norge - norsk - Statens legemiddelverk

imatinib cipla 100 mg

cipla europe nv - imatinibmesilat - kapsel, hard - 100 mg

Imatinib Sandoz 400 mg Norge - norsk - Statens legemiddelverk

imatinib sandoz 400 mg

sandoz - københavn - imatinibmesilat - tablett, filmdrasjert - 400 mg

Imatinib Sandoz 100 mg Norge - norsk - Statens legemiddelverk

imatinib sandoz 100 mg

sandoz - københavn - imatinibmesilat - tablett, filmdrasjert - 100 mg

Pepaxti Den europeiske union - norsk - EMA (European Medicines Agency)

pepaxti

oncopeptides ab - melphalan flufenamide hydrochloride - multippelt myelom - antineoplastiske midler - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Sporanox 100 mg Norge - norsk - Statens legemiddelverk

sporanox 100 mg

2care4 aps - itrakonazol - kapsel, hard - 100 mg